Table 3. Proportion of AML cells in... | American Society of Hematology

Table 3.

Proportion of AML cells in FACS-isolated subpopulations

Patient no.	CD34⁺CD38^–CD71^–, %^*	CD34⁺CD38^–, %†	CD34⁺CD38⁺, %‡	CD34^–, %§
1	1.5	1.9	44.5	12.3
2	17.4	35.3	10.2	14.8
3	0.9	2.4	56	11.8
4	0.3	0.6	40	29.6
5	2.9	3.8	64.9	8.6
6	0.3	0.4	62.4	10.8
7	0.4	0.7	43.1	26.3
8	0.08	0.1	17.3	69.3
9	2.6	4.1	71	5.8
10	2.7	2.9	43.4	21.4
11	0.05	0.08	0.7	67.1
12	0.1	0.1	8.7	43
13	1.6	1.8	62.6	6.1
14	3.2	5.3	45.2	26.1
15	25.3	38.4	24.3	19.5
16	0.4	0.6	52.5	33.2
17	0.6	0.6	90.9	2.1
18	0.2	0.3	23.5	24.3
19	0.7	0.8	2.1	80.9

Patient no.	CD34⁺CD38^–CD71^–, %^*	CD34⁺CD38^–, %†	CD34⁺CD38⁺, %‡	CD34^–, %§
1	1.5	1.9	44.5	12.3
2	17.4	35.3	10.2	14.8
3	0.9	2.4	56	11.8
4	0.3	0.6	40	29.6
5	2.9	3.8	64.9	8.6
6	0.3	0.4	62.4	10.8
7	0.4	0.7	43.1	26.3
8	0.08	0.1	17.3	69.3
9	2.6	4.1	71	5.8
10	2.7	2.9	43.4	21.4
11	0.05	0.08	0.7	67.1
12	0.1	0.1	8.7	43
13	1.6	1.8	62.6	6.1
14	3.2	5.3	45.2	26.1
15	25.3	38.4	24.3	19.5
16	0.4	0.6	52.5	33.2
17	0.6	0.6	90.9	2.1
18	0.2	0.3	23.5	24.3
19	0.7	0.8	2.1	80.9

Mean ± SD = 3.2 ± 6.6

Mean ± SD = 5.3 ± 11.2

Mean ± SD = 40.2 ± 25.3

Mean ± SD = 27 ± 22.9